(38) also reported a higher likelihood of having either luminal/HER2 or HER2-enriched breast tumors in AAs and Latina women from the CCR (AAs: OR= 1.2, 95% CI, 1.1-1.3; Latinas: OR= 1.1, 95% CI, 1.0-1.2). Here, ERBB2 is linked to breast neoplasm.